Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Camkurt MA, Gülpamuk G, Fındiklı E, Elve R.
PMID: 28449567
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):181-183. doi: 10.9758/cpn.2017.15.2.181.

Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the...

Cite
Camkurt MA, Gülpamuk G, Fındiklı E, et al. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clin Psychopharmacol Neurosci. 2017;15(2):181-183doi: 10.9758/cpn.2017.15.2.181.
Camkurt, M. A., Gülpamuk, G., Fındiklı, E., & Elve, R. (2017). Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(2), 181-183. https://doi.org/10.9758/cpn.2017.15.2.181
Camkurt, Mehmet Akif, et al. "Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 15,2 (2017): 181-183. doi: https://doi.org/10.9758/cpn.2017.15.2.181
Camkurt MA, Gülpamuk G, Fındiklı E, Elve R. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):181-183. doi: 10.9758/cpn.2017.15.2.181. PMID: 28449567; PMCID: PMC5426493.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 12616965
Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002;24(10):703-29
Bayés, M., Rabasseda, X., & Prous, J. R. (2002). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 24(10), 703-29.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 24,10 (2002): 703-29.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29. PMID: 12616965.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 16082422
Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):331-72.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005;27(5):331-72
Bayés, M., Rabasseda, X., & Prous, J. R. (2005). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 27(5), 331-72.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 27,5 (2005): 331-72.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):331-72. PMID: 16082422.
Copy Download .nbib Format: NLM
Modulation of venlafaxine hydrochloride release from press coated matrix tablet.

Indian journal of pharmaceutical sciences

Gohel MC, Soni CD, Nagori SA, Sarvaiya KG.
PMID: 20046735
Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974.

The aim of present study was to prepare novel modified release press coated tablets of venlafaxine hydrochloride. Hydroxypropylmethylcellulose K4M and hydroxypropylmethylcellulose K100M were used as release modifier in core and coat, respectively. A 3(2) full factorial design was adopted...

Cite
Gohel MC, Soni CD, Nagori SA, et al. Modulation of venlafaxine hydrochloride release from press coated matrix tablet. Indian J Pharm Sci. 2008;70(3):292-7doi: 10.4103/0250-474X.42974.
Gohel, M. C., Soni, C. D., Nagori, S. A., & Sarvaiya, K. G. (2008). Modulation of venlafaxine hydrochloride release from press coated matrix tablet. Indian journal of pharmaceutical sciences, 70(3), 292-7. https://doi.org/10.4103/0250-474X.42974
Gohel, M C, et al. "Modulation of venlafaxine hydrochloride release from press coated matrix tablet." Indian journal of pharmaceutical sciences vol. 70,3 (2008): 292-7. doi: https://doi.org/10.4103/0250-474X.42974
Gohel MC, Soni CD, Nagori SA, Sarvaiya KG. Modulation of venlafaxine hydrochloride release from press coated matrix tablet. Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974. PMID: 20046735; PMCID: PMC2792530.
Copy Download .nbib Format: NLM
Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form.

Indian journal of pharmaceutical sciences

Chhalotiya UK, Patel HB, Bhatt KK.
PMID: 21969762
Indian J Pharm Sci. 2010 Nov;72(6):814-8. doi: 10.4103/0250-474X.84605.

A simple, specific, accurate, and precise ultra performance liquid chromatographic method was developed and validated for the estimation of venlafaxine hydrochloride in tablet dosage forms. A acquity TM BEH column having C18, 100×2.1 mm i.d. in isocratic mode, with...

Cite
Chhalotiya UK, Patel HB, Bhatt KK. Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form. Indian J Pharm Sci. 2010;72(6):814-8doi: 10.4103/0250-474X.84605.
Chhalotiya, U. K., Patel, H. B., & Bhatt, K. K. (2010). Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form. Indian journal of pharmaceutical sciences, 72(6), 814-8. https://doi.org/10.4103/0250-474X.84605
Chhalotiya, U K, et al. "Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form." Indian journal of pharmaceutical sciences vol. 72,6 (2010): 814-8. doi: https://doi.org/10.4103/0250-474X.84605
Chhalotiya UK, Patel HB, Bhatt KK. Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form. Indian J Pharm Sci. 2010 Nov;72(6):814-8. doi: 10.4103/0250-474X.84605. PMID: 21969762; PMCID: PMC3178991.
Copy Download .nbib Format: NLM
Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Al-Mogherah AI, Ibrahim MA, Hassan MA.
PMID: 33250644
Saudi Pharm J. 2020 Nov;28(11):1374-1382. doi: 10.1016/j.jsps.2020.09.001. Epub 2020 Sep 12.

Three factors, three levels (3

Cite
Al-Mogherah AI, Ibrahim MA, Hassan MA. Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films. Saudi Pharm J. 2020;28(11):1374-1382doi: 10.1016/j.jsps.2020.09.001.
Al-Mogherah, A. I., Ibrahim, M. A., & Hassan, M. A. (2020). Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 28(11), 1374-1382. https://doi.org/10.1016/j.jsps.2020.09.001
Al-Mogherah, Arwa Ibrahim, et al. "Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 28,11 (2020): 1374-1382. doi: https://doi.org/10.1016/j.jsps.2020.09.001
Al-Mogherah AI, Ibrahim MA, Hassan MA. Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films. Saudi Pharm J. 2020 Nov;28(11):1374-1382. doi: 10.1016/j.jsps.2020.09.001. Epub 2020 Sep 12. PMID: 33250644; PMCID: PMC7679467.
Copy Download .nbib Format: NLM
Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride.

Scientifica

Misra R, Bhardwaj P.
PMID: 27274884
Scientifica (Cairo). 2016;2016:4282986. doi: 10.1155/2016/4282986. Epub 2016 May 05.

The present investigation is concerned about the development of floating bioadhesive drug delivery system of venlafaxine hydrochloride which after oral administration exhibits a unique combination of floating and bioadhesion to prolong gastric residence time and increase drug bioavailability within...

Cite
Misra R, Bhardwaj P. Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride. Scientifica (Cairo). 2016;2016:4282986doi: 10.1155/2016/4282986.
Misra, R., & Bhardwaj, P. (2016). Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride. Scientifica, 20164282986. https://doi.org/10.1155/2016/4282986
Misra, Raghvendra, and Bhardwaj, Peeyush. "Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride." Scientifica vol. 2016 (2016): 4282986. doi: https://doi.org/10.1155/2016/4282986
Misra R, Bhardwaj P. Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride. Scientifica (Cairo). 2016;2016:4282986. doi: 10.1155/2016/4282986. Epub 2016 May 05. PMID: 27274884; PMCID: PMC4871974.
Copy Download .nbib Format: NLM
Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet.

Indian journal of pharmaceutical sciences

Bhalekar MR, Madgulkar AR, Sheladiya DD, Kshirsagar SJ, Wable ND, Desale SS.
PMID: 20046773
Indian J Pharm Sci. 2008 Jul-Aug;70(4):472-6. doi: 10.4103/0250-474X.44596.

The purpose of this research was to prepare a sustained release drug delivery system of venlafaxine hydrochloride by using a wax matrix system. The effects of bees wax and carnauba wax on drug release profile was investigated. A 3(2)...

Cite
Bhalekar MR, Madgulkar AR, Sheladiya DD, et al. Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet. Indian J Pharm Sci. 2008;70(4):472-6doi: 10.4103/0250-474X.44596.
Bhalekar, M. R., Madgulkar, A. R., Sheladiya, D. D., Kshirsagar, S. J., Wable, N. D., & Desale, S. S. (2008). Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet. Indian journal of pharmaceutical sciences, 70(4), 472-6. https://doi.org/10.4103/0250-474X.44596
Bhalekar, M R, et al. "Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet." Indian journal of pharmaceutical sciences vol. 70,4 (2008): 472-6. doi: https://doi.org/10.4103/0250-474X.44596
Bhalekar MR, Madgulkar AR, Sheladiya DD, Kshirsagar SJ, Wable ND, Desale SS. Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet. Indian J Pharm Sci. 2008 Jul-Aug;70(4):472-6. doi: 10.4103/0250-474X.44596. PMID: 20046773; PMCID: PMC2792543.
Copy Download .nbib Format: NLM
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride.

Frontiers in pharmacology

Momin MM, Kane S, Abhang P.
PMID: 26217229
Front Pharmacol. 2015 Jul 09;6:144. doi: 10.3389/fphar.2015.00144. eCollection 2015.

The aim of the present research was to develop a bilayer tablet of venlafaxine hydrochloride for bimodal drug release. In the present investigation authors have tried to explore fenugreek mucilage (FNM) for bioadhesive sustained release layer. The attempt has...

Cite
Momin MM, Kane S, Abhang P. Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride. Front Pharmacol. 2015;6:144doi: 10.3389/fphar.2015.00144.
Momin, M. M., Kane, S., & Abhang, P. (2015). Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride. Frontiers in pharmacology, 6144. https://doi.org/10.3389/fphar.2015.00144
Momin, Munira M, et al. "Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride." Frontiers in pharmacology vol. 6 (2015): 144. doi: https://doi.org/10.3389/fphar.2015.00144
Momin MM, Kane S, Abhang P. Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride. Front Pharmacol. 2015 Jul 09;6:144. doi: 10.3389/fphar.2015.00144. eCollection 2015. PMID: 26217229; PMCID: PMC4496574.
Copy Download .nbib Format: NLM
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

JMIR public health and surveillance

Anderson LS, Bell HG, Gilbert M, Davidson JE, Winter C, Barratt MJ, Win B, Painter JL, Menone C, Sayegh J, Dasgupta N.
PMID: 28148472
JMIR Public Health Surveill. 2017 Feb 01;3(1):e6. doi: 10.2196/publichealth.6174.

BACKGROUND: The nonmedical use of pharmaceutical products has become a significant public health concern. Traditionally, the evaluation of nonmedical use has focused on controlled substances with addiction risk. Currently, there is no effective means of evaluating the nonmedical use...

Cite
Anderson LS, Bell HG, Gilbert M, et al. Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. JMIR Public Health Surveill. 2017;3(1):e6doi: 10.2196/publichealth.6174.
Anderson, L. S., Bell, H. G., Gilbert, M., Davidson, J. E., Winter, C., Barratt, M. J., Win, B., Painter, J. L., Menone, C., Sayegh, J., & Dasgupta, N. (2017). Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. JMIR public health and surveillance, 3(1), e6. https://doi.org/10.2196/publichealth.6174
Anderson, Laurie S, et al. "Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis." JMIR public health and surveillance vol. 3,1 (2017): e6. doi: https://doi.org/10.2196/publichealth.6174
Anderson LS, Bell HG, Gilbert M, Davidson JE, Winter C, Barratt MJ, Win B, Painter JL, Menone C, Sayegh J, Dasgupta N. Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. JMIR Public Health Surveill. 2017 Feb 01;3(1):e6. doi: 10.2196/publichealth.6174. PMID: 28148472; PMCID: PMC5311422.
Copy Download .nbib Format: NLM
3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.

Journal of pharmaceutical sciences

Zhao X, Wei W, Niu R, Li Q, Hu C, Jiang S.
PMID: 34303671
J Pharm Sci. 2022 Jan;111(1):116-123. doi: 10.1016/j.xphs.2021.07.010. Epub 2021 Jul 22.

This work aimed to use hot-melt extrusion (HME) and dual fused deposition modeling (FDM) 3D printing technology to develop a novel intragastric floating and sustained-release drug delivery system. The intragastric floating and sustained-release tablet was engineered by employing hydroxypropyl...

Cite
Zhao X, Wei W, Niu R, et al. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers. J Pharm Sci. 2021;111(1):116-123doi: 10.1016/j.xphs.2021.07.010.
Zhao, X., Wei, W., Niu, R., Li, Q., Hu, C., & Jiang, S. (2022). 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers. Journal of pharmaceutical sciences, 111(1), 116-123. https://doi.org/10.1016/j.xphs.2021.07.010
Zhao, Xinyu, et al. "3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers." Journal of pharmaceutical sciences vol. 111,1 (2022): 116-123. doi: https://doi.org/10.1016/j.xphs.2021.07.010
Zhao X, Wei W, Niu R, Li Q, Hu C, Jiang S. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers. J Pharm Sci. 2022 Jan;111(1):116-123. doi: 10.1016/j.xphs.2021.07.010. Epub 2021 Jul 22. PMID: 34303671.
Copy Download .nbib Format: NLM
Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan-carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating.

Asian journal of pharmaceutical sciences

Zhang X, Gu X, Wang X, Wang H, Mao S.
PMID: 32104430
Asian J Pharm Sci. 2018 Nov;13(6):566-574. doi: 10.1016/j.ajps.2018.01.004. Epub 2018 Mar 02.

The objective of this study is to design sustained-release tablets using matrix technology, which can well control the release of highly water-soluble drugs with good system robustness and simple preparation process. Taking venlafaxine hydrochloride (VH) as a drug model,...

Cite
Zhang X, Gu X, Wang X, et al. Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan-carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating. Asian J Pharm Sci. 2018;13(6):566-574doi: 10.1016/j.ajps.2018.01.004.
Zhang, X., Gu, X., Wang, X., Wang, H., & Mao, S. (2018). Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan-carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating. Asian journal of pharmaceutical sciences, 13(6), 566-574. https://doi.org/10.1016/j.ajps.2018.01.004
Zhang, Xiaofei, et al. "Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan-carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating." Asian journal of pharmaceutical sciences vol. 13,6 (2018): 566-574. doi: https://doi.org/10.1016/j.ajps.2018.01.004
Zhang X, Gu X, Wang X, Wang H, Mao S. Tunable and sustained-release characteristics of venlafaxine hydrochloride from chitosan-carbomer matrix tablets based on in situ formed polyelectrolyte complex film coating. Asian J Pharm Sci. 2018 Nov;13(6):566-574. doi: 10.1016/j.ajps.2018.01.004. Epub 2018 Mar 02. PMID: 32104430; PMCID: PMC7032170.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries